PWPS
FENC icon

Pinnacle Wealth Planning Services’s Fennec Pharmaceuticals FENC Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.45K Hold
507
– – ﹤0.01% 2270
2026
Q1 		$3.12K Hold
507
– – ﹤0.01% 2359
2025
Q4 		$3.9K Buy
+507
New +$4.16K ﹤0.01% 2341
2025
Q2 		– Sell
-15,419
Closed -$93.9K – 466
2025
Q1 		$93.9K Buy
15,419
+31
+0.2% +$199 0.01% 385
2024
Q4 		$97.3K Buy
+15,388
New +$78.8K 0.01% 371
2024
Q3 		– Sell
-12,289
Closed -$75.1K – 541
2024
Q2 		$75.1K Buy
+12,289
New +$102K 0.01% 491

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Pinnacle Wealth Planning Services's FENC Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Fennec Pharmaceuticals (FENC) position steady in Q2 2026 at 507 shares worth $5.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

Pinnacle Wealth Planning Services first reported a position in FENC in Q2 2024 and has held it in 6 quarters since. The position peaked at $97.3K in Q4 2024. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Pinnacle Wealth Planning Services held 507 shares of Fennec Pharmaceuticals worth $5.45K as of Q2 2026.
  • Pinnacle Wealth Planning Services left its Fennec Pharmaceuticals share count unchanged in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2270 holding.
  • Pinnacle Wealth Planning Services first reported a position in Fennec Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • Pinnacle Wealth Planning Services's Fennec Pharmaceuticals position peaked at $97.3K in Q4 2024.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.